Free Trial

Brooklyn ImmunoTherapeutics (BTX) News Today

Brooklyn ImmunoTherapeutics logo
$0.25 +0.00 (+1.05%)
(As of 12/20/2024 ET)
Brooklyn ImmunoTherapeutics Inc stock logo
Brooklyn ImmunoTherapeutics (NYSE:BTX) Coverage Initiated by Analysts at StockNews.com
StockNews.com started coverage on Brooklyn ImmunoTherapeutics in a research note on Thursday. They issued a "hold" rating on the stock.
Brooklyn ImmunoTherapeutics Inc stock logo
Brooklyn ImmunoTherapeutics (NYSE:BTX) Research Coverage Started at StockNews.com
StockNews.com started coverage on Brooklyn ImmunoTherapeutics in a research report on Tuesday. They set a "hold" rating for the company.
'Brooklyn Nine-Nine' star Andre Braugher dies at 61
Brooklyn Bridge
Brooklyn Bedding Coupon for November
Brooklyn Hospital Center
Brooklyn Technical High School
Brooklyn Preparatory High School
Brooklyn ImmunoTherapeutics Announces Board Changes
Get Brooklyn ImmunoTherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BTX and its competitors with MarketBeat's FREE daily newsletter.

Has Trump Finally Gone Too Far? (Ad)

Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.

Register For The Webinar To Discover

BTX Media Mentions By Week

BTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BTX
News Sentiment

0.00

0.00

Average
Information
News Sentiment

BTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BTX Articles
This Week

1

0

BTX Articles
Average Week

Get Brooklyn ImmunoTherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BTX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:BTX) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners